Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event.

@article{Rauer2006AntimyelinAA,
  title={Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event.},
  author={Sebastian Rauer and B L Euler and Markus Reindl and Th Berger},
  journal={Journal of neurology, neurosurgery, and psychiatry},
  year={2006},
  volume={77 6},
  pages={739-42}
}
AIM To investigate whether the presence of serum antibodies against myelin oligodendrocyte glycoprotein (MOG) and myelin basic protein (MBP) in patients with a clinically isolated syndrome (CIS) predicts the interval to develop more frequently and earlier a first relapse (clinically definite multiple sclerosis: CDMS) than seronegative patients. METHODS Sera from 45 patients with a CIS and positive intrathecal IgG-synthesis were retrospectively tested for the presence of IgM antibodies against… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

Disease Biomarkers in Multiple Sclerosis

Molecular Diagnosis & Therapy • 2012
View 1 Excerpt

Similar Papers

Loading similar papers…